Oric Pharmaceuticals (ORIC) Return on Capital Employed (2020 - 2026)
Oric Pharmaceuticals (ORIC) posted Return on Capital Employed of 37.01% for Q1 2026, down 3.42% on a QoQ basis from 35.78% in Q4 2025, and up 2386.0% year-over-year from 1.49% in Q1 2025.
Oric Pharmaceuticals (ORIC) Return on Capital Employed (2020 - 2026) Analysis & Trends
Oric Pharmaceuticals' Return on Capital Employed history runs 7 years deep, the most recent figure standing at 37.01% for Q1 2026.
- Quarterly Return on Capital Employed rose 2386.0% year-over-year to 37.01% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 37.01% (up 2386.0% YoY) and the FY2025 annual result came in at 44.54%, up 1545.0% from the prior year.
- Return on Capital Employed was 37.01% for Q1 2026 at Oric Pharmaceuticals, down from 35.78% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 31.11% in Q1 2022 and bottomed at 60.87% in Q1 2025.
- A 5-year average of 42.22% and a median of 40.13% in 2025 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2025 — Return on Capital Employed sank 2100 bps — and 2026, when it soared 2386 bps.
- Oric Pharmaceuticals' Return on Capital Employed stood at 40.39% in 2022, then declined by 13 bps to 45.64% in 2023, then slipped by 19 bps to 54.28% in 2024, then jumped by 34 bps to 35.78% in 2025, then fell by 3 bps to 37.01% in 2026.
- Business Quant data shows ORIC's Return on Capital Employed at 37.01% in Q1 2026, 35.78% in Q4 2025, and 40.13% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -31.80% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.46% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -68.47% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 21.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 10.19% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -68.84% |
| 10 | Oric Pharmaceuticals | 1.15 Bn | 866.67 Mn | - | -37.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -37.01% |
| Dec 31, 2025 | -35.78% |
| Sep 30, 2025 | -40.13% |
| Jun 30, 2025 | -54.07% |
| Mar 31, 2025 | -60.87% |
| Dec 31, 2024 | -54.28% |
| Sep 30, 2024 | -45.80% |
| Jun 30, 2024 | -39.06% |
| Mar 31, 2024 | -39.87% |
| Dec 31, 2023 | -45.64% |
| Sep 30, 2023 | -38.42% |
| Jun 30, 2023 | -40.25% |
| Mar 31, 2023 | -42.42% |
| Dec 31, 2022 | -40.39% |
| Sep 30, 2022 | -39.25% |
| Jun 30, 2022 | -33.43% |
| Mar 31, 2022 | -31.11% |
| Dec 31, 2021 | -27.08% |
| Sep 30, 2021 | -30.20% |
| Jun 30, 2021 | -34.37% |